- Human（2）
- Mouse（1）
No data
- His Tag（2）
- Tag Free（1）
No data
- HEK293（3）
No data
- Unconjugated（3）
No data
- RUO（3）
No data
- No（3）
No data
- 50ug/$367.00
- 1mg/$2205.00
No data
- 50ug/$360.00
- 1mg/$2165.00
No data
- 20ug/$260.00
- 100ug/$980.00
- 500ug/$3295.00
No data
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| Cathepsin L | Human Cathepsin L / CTSL1 Protein, Tag Free (Pro-form, HPLC verified) |  Human | HEK293 |  | HPLCSDS-PAGE | $367.00 50ug | ||
| Cathepsin L | Human Cathepsin L / CTSL1 Protein, His Tag (Pro-form) | Human | HEK293 |  | SDS-PAGE | $360.00 50ug | ||
| Cathepsin L | Mouse Cathepsin L / CTSL1 Protein, His Tag (Pro-form, MALS verified) |  Mouse | HEK293 |  | MALSSDS-PAGE | $260.00 20ug |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Olgotrelvir | STI-1558; STI1558 | Approved | Texas A&M University | Ovydso, 奥维宁 | Mainland China | Coronavirus Disease 2019 (COVID-19) | Zhejiang Acea Pharmaceutical Co Ltd | 2025-10-28 | Coronavirus Disease 2019 (COVID-19); Pulmonary Disease, Chronic Obstructive | Details |
